Delinea Identity Threat Protection vs Imprivata Access Intelligence Platform (AIP): Side-by-Side Comparison (2026)

Delinea Identity Threat Protection

Teams managing hybrid identity sprawl across SaaS, cloud, and on-premises systems need Delinea Identity Threat Protection because it actually maps lateral movement risk by visualizing identity access pathways instead of just flagging isolated anomalies. The continuous monitoring and AI-driven impact assessment align directly with NIST DE.CM and DE.AE, catching account takeovers and MFA attacks that simpler tools miss. Skip this if your environment is purely on-premises Active Directory with minimal SaaS integration; you'll pay for cloud-native capabilities you don't need.

Imprivata Access Intelligence Platform (AIP)

Healthcare security teams managing clinician access at scale need Imprivata Access Intelligence Platform for one reason: it catches inappropriate record access and drug diversion patterns that generic UEBA tools miss because they understand healthcare workflows instead of treating all logins as equivalent. The platform covers NIST DE.CM and DE.AE across millions of patient interactions, with mobile analytics that matters when half your users access records from phones. Skip this if your organization doesn't care about regulatory audit trails or patient privacy breaches tied to specific users; AIP assumes you're tracking access intent, not just anomalies.